George L. Sing, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 3,300 shares at $609.68 ($2.0M) on 2020-06-29, disclosed to the SEC on 2020-06-29.
Open-market sale of $2.0M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $606.80 | 200 | $121K | 6.0% |
| 2 | $606.80 | 200 | $121K | 6.0% |
| 3 | $607.54 | 200 | $122K | 6.0% |
| 4 | $608.29 | 500 | $304K | 15.1% |
| 5 | $609.37 | 1,500 | $914K | 45.5% |
| 6 | $609.37 | 500 |
| $305K |
| 15.2% |
| 7 | $609.68 | 100 | $61K | 3.0% |
| 8 | $609.68 | 100 | $61K | 3.0% |
| Total | $608.80 avg | 3,300 | $2.0M | 100% |
| Filing → |
| REGN | SELL | 2024-02-12 | $950K | — | Filing → |
| REGN | SELL | 2022-03-01 | $2.5M | — | Filing → |
| REGN | SELL | 2021-11-23 | $2.0M | — | Filing → |